Page 14 - Serum Institute Of India

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

PM taking indigenous vaccine should remove doubts on side-effects: Vardhan

Prime Minister Narendra Modi taking an indigenously developed COVID-19 vaccine should remove all doubts that people have about its side-effects, Harsh Vardhan said

Chinese hackers targeted Serum, Bharat Biotech, says security firm

Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than 60 per cent of all vaccines sold in the world

Top headlines: PM Modi receives Covid jab; ATF price raised by a steep 6.5%

Business Standard brings you top news of the evening

Serum's Poonawalla apprises Amit Shah about Covid-19 vaccine rollout

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country. "It was my honour to brief you today, Shri Hon'ble @AmitShah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India," Poonawalla said in a tweet. In January, thecountry's drugs regulator had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. Apart from making efforts to meet the requirements of India, SII, the world's largest vaccine maker, is also trying its best to balance the needs of the rest of the world.

'Tie-up with Serum Institute key to mass production of Covid-19 vaccines'

Located in the city of Pune in Maharashtra, the SII is the world''s largest vaccine manufacturer by volume

Expert panel asks DRL to come back with more data on Sputnik safety

DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months

Serum Institute to export Covid-19 vaccine to 25-30 countries on Tuesday

Bharat Bio says keen to follow, have capacity of 40 mn doses a month

Poonawalla urges countries to be patient, Serum to prioritise India needs

Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added

Novavax, Serum Institute plans to supply 1.1 billion doses to COVAX

Novavax has signed a memorandum of understanding (MoU) in this regard with Gavi, the Vaccine Alliance.

Covid-19 vaccination: Serum Institute to gain from G7's boost to COVAX

The immediate contribution will be $2 billion. More than 180 nations are yet to administer a single dose of the Covid vaccine

Poonawalla group firm makes open offer to buy addl stake in Magma Fincorp

Adar Poonawalla-controlled Rising Sun Holdings Pvt Ltd along with two other individuals have made an open offer to buy an additional 26 per cent stake in non-banking financial company Magma Fincorp

With WHO backing, SII to ship Astra Covid-19 vaccine to 70 countries

After audit of Pune plant, Serum may supply vaccines to UK as well

Haven't asked Serum to take back 1 mn Covishield doses, says South Africa

South Africa plans to share AstraZeneca shots via African Union, says Anban Pillay, deputy director-general at the Department of Health

Poonawalla's buyout to aid Magma Fincorp's expansion plans: Analysts

With Poonawalla taking control and fortunes of Magma Fincorp (MFL) expected to change, investors rushed to buy the latter's shares which were locked in the 10 per cent upper circuit band

Adar Poonawalla to acquire 60% in Magma Fincorp for Rs 3,456-crore

As a part of deal, Magma will get fresh capital of Rs 3,456 crore

A shot at recovery

Vaccine delivery needs to move beyond govt control

Top headlines: Setback for Amazon, India to appeal against Cairn verdict

On Monday, the central bank said it would buy bonds worth Rs 20,000 crore from the secondary markets on Wednesday. Read top news with Business Standard here

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

India Coronavirus Dispatch: Serum sitting on a stockpile of 55 mn shots

The nationwide 'R-value' stays steady, over 5 million people vaccinated, Indians locked out of Saudi, and more-news relevant to India's fight against Covid-19